Armata Pharmaceuticals, Inc. - Director's Dealing 2005

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2005-08-04

Reporting Person: BIOGEN IDEC INC (10% Owner)
Reporting Person: BIOGEN IDEC MA INC (10% Owner)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2005-08-04	Common Stock, $0.01 Par Value	S	7500	$0.76	Disposed	11798748	Indirect
2005-08-04	Common Stock, $0.01 Par Value	S	2500	$0.77	Disposed	11796248	Indirect
2005-08-04	Common Stock, $0.01 Par Value	S	2500	$0.78	Disposed	11793748	Indirect
2005-08-05	Common Stock, $0.01 Par Value	S	16400	$0.76	Disposed	11777348	Indirect
2005-08-05	Common Stock, $0.01 Par Value	S	1000	$0.7602	Disposed	11776348	Indirect
2005-08-05	Common Stock, $0.01 Par Value	S	100	$0.761	Disposed	11776248	Indirect
2005-08-05	Common Stock, $0.01 Par Value	S	5000	$0.77	Disposed	11771248	Indirect
2005-08-05	Common Stock, $0.01 Par Value	S	2500	$0.78	Disposed	11768748	Indirect

F1: Shares are owned indirectly by Biogen Idec Inc. and directly by its wholly-owned subsidiary Biogen Idec MA Inc., fka Biogen, Inc.